Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey

被引:173
作者
Dionisi-Vici, C
Rizzo, C
Burlina, AB
Caruso, U
Sabetta, G
Uziel, G
Abeni, D
机构
[1] Bambino Gesu Pediat Hosp, Dept Metab, IRCCS, I-00165 Rome, Italy
[2] Univ Padua, Dept Pediat, Padua, Italy
[3] Gaslini Hosp, Dept Pediat, IRCCS, Genoa, Italy
[4] IRCCS, Neurol Inst C Besta, Milan, Italy
[5] IRCCS, Ist Dermatol Immacolta, Clin Epidemiol Unit, Rome, Italy
关键词
D O I
10.1067/mpd.2002.122394
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To estimate at the national level the overall and disease-specific incidence of inborn errors of metabolism not mass screened at birth. Study design: Prospective nonconcurrent study (1985-1997) on patients 0 to 17 years of age, diagnosed in 23 Italian pediatric reference centers. Results: Cases (n = 1935). were recruited representing an incidence of 1:3707 live births for similar to200 diseases. In the last 5 years the incidence was 1:2758, reflecting improved diagnostic facilities, better coverage, increased medical awareness, and newly discovered diseases. In this period, the most frequent classes of diseases were lysosomal storage disease, 1:8275; disorders of carbohydrate metabolism, 1:19,532; organic acidopathies, 1:21,422; and primary lactic acidemias, 1:27,106. The most frequent individual diseases were Gaucher type I, 1:40,247; glycogenosis type la, 1:57,746; methylmalonic acidurias, 1:61,775; and ornithine transcarbamylase deficiency, 1:69,904. The incidence of diseases potentially identifiable with the use of a new neonatal mass screening technique is 1:6200. Of surviving patients, 11% reached adulthood by the end of the study. Conclusions: Inborn errors of metabolism constitute a highly heterogeneous category of rare diseases, representing a relevant cause of morbidity and mortality in childhood. This study quantifies the minimum size of the disease burden, providing useful tools for public health and health policy planning.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 29 条
[1]  
[Anonymous], EDA EXPLORATORY DATA
[2]   Incidence of inborn errors of metabolism in British Columbia, 1969-1996 [J].
Applegarth, DA ;
Toone, JR ;
Lowry, RB .
PEDIATRICS, 2000, 105 (01) :art. no.-e10
[3]   Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening [J].
Bezman, L ;
Moser, AB ;
Raymond, GV ;
Rinaldo, P ;
Watkins, PA ;
Smith, KD ;
Kass, NE ;
Moser, HW .
ANNALS OF NEUROLOGY, 2001, 49 (04) :512-517
[4]   The adult and adolescent clinic for inborn errors of metabolism [J].
Brenton, DP .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (03) :215-228
[5]  
Cerone R, 1998, P 8 NAT C NEON SCREE
[6]   Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism [J].
Coelho, JC ;
Wajner, M ;
Burin, MG ;
Vargas, CR ;
Giugliani, R .
EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (08) :650-654
[7]  
Dean AG., 1995, Epi info: a word-processing, database, and statistics program for public health on IBM-compatible microcomputers
[8]   A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies [J].
Eng, CM ;
Banikazemi, M ;
Gordon, RE ;
Goldman, M ;
Phelps, R ;
Kim, L ;
Gass, A ;
Winston, J ;
Dikman, S ;
Fallon, JT ;
Brodie, S ;
Stacy, CB ;
Mehta, D ;
Parsons, R ;
Norton, K ;
O'Callaghan, M ;
Desnick, RJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :711-722
[9]  
Fleiss JL, 1981, STAT METHODS RATES P
[10]  
Garrod A. E., 1908, INBORN ERRORS METABO